Current and prospective pharmacological targets in relation to antimigraine action

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 378, Issue 4, 2008, Pages 371-394

  Mehrotra, Suneet ^a   Gupta, Saurabh ^a   Chan, Kayi Y ^a   Villalón, Carlos M ^b   Centurión, David ^b   Saxena, Pramod R ^a   MaassenVanDenBrink, Antoinette ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT; Antimigraine drugs; CGRP; Migraine; Noradrenaline; Receptors

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; 5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADENOSINE RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMPA RECEPTOR; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; BW 723 C 86; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIHYDROERGOTAMINE; DIZOCILPINE; DOPAMINE RECEPTOR; ENDOTHELIN RECEPTOR; ERGOTAMINE; ESTROGEN RECEPTOR; ISOMETHEPTENE; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; METERGOLINE; METOCLOPRAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PNU 142633; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE; SB 258741; SB 269970 A; SB 626104 A; SEROTONIN 2 ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CORONARY ARTERY CONSTRICTION; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TARGETING; EXPERIMENTAL MODEL; HUMAN; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR AFFINITY; REVIEW; SYMPTOMATOLOGY;

EID: 51749089518     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0322-7     Document Type: Review

References (330)

1. RP Ahlquist 1967 Development of the concept of alpha and beta adrenotropic receptors Ann N Y Acad Sci 139 549 552
2. S Akerman PJ Goadsby 2005 The role of dopamine in a model of trigeminovascular nociception J Pharmacol Exp Ther 314 162 169
3. S Akerman PJ Goadsby 2007 Dopamine and migraine: biology and clinical implications Cephalalgia 27 1308 1314
4. S Akerman DJ Williamson RG Hill PJ Goadsby 2001 The effect of adrenergic compounds on neurogenic dural vasodilatation Eur J Pharmacol 424 53 58
5. S Akerman DJ Williamson H Kaube PJ Goadsby 2002 The role of histamine in dural vessel dilation Brain Res 956 96 102
6. S Akerman DJ Williamson PJ Goadsby 2003 Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism Br J Pharmacol 140 558 566
7. SP Alexander A Mathie JA Peters 2007 Guide to receptors and channels, 2nd edition (2007 revision) Br J Pharmacol 150 Suppl 1 S1
8. AM Aloisi 2003 Gonadal hormones and sex differences in pain reactivity Clin J Pain 19 168 174
9. M Anthony JW Lance 1989 Plasma serotonin in patients with chronic tension headaches J Neurol Neurosurg Psychiatry 52 182 184
10. M Anthony H Hinterberger JW Lance 1967 Plasma serotonin in migraine and stress Arch Neurol 16 544 552
11. JR Arch AT Ainsworth MA Cawthorne V Piercy MV Sennitt VE Thody C Wilson S Wilson 1984 Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs Nature 309 163 165
12. U Arulmani A MaassenVanDenBrink CM Villalón PR Saxena 2004 Calcitonin gene-related peptide and its role in migraine pathophysiology Eur J Pharmacol 500 315 330
13. 1 receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs Cephalalgia 25 1082 1090
14. U Arulmani S Gupta A MaassenVanDenBrink D Centurión CM Villalón PR Saxena 2006 Experimental migraine models and their relevance in migraine therapy Cephalalgia 26 642 659
15. G Attali A Weizman I Gil-Ad M Rehavi 1997 Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters Brain Res 756 153 159
16. T Attina R Camidge DE Newby DJ Webb 2005 Endothelin antagonism in pulmonary hypertension, heart failure, and beyond Heart 91 825 831
17. 5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci Lett 207 73 76
18. 4 receptors on lymphocytes Cephalalgia 20 15 19
19. EA Barnard P Skolnick RW Olsen H Mohler W Sieghart G Biggio C Braestrup AN Bateson SZ Langer 1998 International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function Pharmacol Rev 50 291 313
20. NM Barnes T Sharp 1999 A review of central 5-HT receptors and their function Neuropharmacology 38 1083 1152
21. JB Becker CN Rudick 1999 Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study Pharmacol Biochem Behav 64 53 57
22. WI Bender 1995 ACE inhibitors for prophylaxis of migraine headaches Headache 35 470 471
23. AD Bennett KM Chastain CE Hulsebosch 2000 Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain Pain 86 163 175
24. A Bergerot RJ Storer PJ Goadsby 2007 Dopamine inhibits trigeminovascular transmission in the rat Ann Neurol 61 251 262
25. ME Bigal CA Bordini SJ Tepper JG Speciali 2002 Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study Cephalalgia 22 345 353
26. 2C- adrenergic receptor subtype in the opossum kidney and in the OK cell line J Pharmacol Exp Ther 259 323 329
27. O Blin JP Azulay G Masson G Aubrespy G Serratrice 1991 Apomorphine-induced yawning in migraine patients: enhanced responsiveness Clin Neuropharmacol 14 91 95
28. M Boccuni M Alessandri BM Fusco F Cangi 1989 The pressor hyperresponsiveness to phenylephrine unmasks sympathetic hypofunction in migraine Cephalalgia 9 239 245
29. 1-like receptors in the carotid circulation of the pigs Br J Pharmacol 94 327P
30. RA Bond DE Clarke 1988 Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α- and β-subtypes Br J Pharmacol 95 723 734
31. NG Bowery B Bettler W Froestl JP Gallagher F Marshall M Raiteri TI Bonner SJ Enna 2002 International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function Pharmacol Rev 54 247 264
32. SD Brain AD Grant 2004 Vascular actions of calcitonin gene-related peptide and adrenomedullin Physiol Rev 84 903 934
33. JL Brandes JR Saper M Diamond JR Couch DW Lewis J Schmitt W Neto S Schwabe D Jacobs 2004 Topiramate for migraine prevention: a randomized controlled trial JAMA 291 965 973
34. JM Brundege TV Dunwiddie 1997 Role of adenosine as a modulator of synaptic activity in the central nervous system Adv Pharmacol 39 353 391
35. TM Buchanan NM Ramadan S Aurora 2004 Future pharmacologic targets for acute and preventive treatments of migraine Expert Rev Neurother 4 391 430
36. 2C receptor genes as candidate genes for migraine Headache 36 254 258
37. 2X receptors in sensory neurones Br J Anaesth 84 476 488
38. R Burstein MF Cutrer D Yarnitsky 2000 The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine Brain 123 Pt 8 1703 1709
39. 2-adrenoceptors: pharmacological and molecular biological evidence converge Trends Pharmacol Sci 9 356 361
40. 2- adrenergic receptors Faseb J 6 832 839
41. 2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype J Pharmacol Exp Ther 245 600 607
42. DB Bylund DC Eikenberg JP Hieble SZ Langer RJ Lefkowitz KP Minneman PB Molinoff RR Ruffolo Jr U Trendelenburg 1994 International Union of Pharmacology nomenclature of adrenoceptors Pharmacol Rev 46 121 136
43. DB Bylund JW Regan JE Faber JP Hieble CR Triggle RR Ruffolo Jr 1995 Vascular α-adrenoceptors: from the gene to the human Can J Physiol Pharmacol 73 533 543
44. AH Calhoun 2004 A novel specific prophylaxis for menstrual-associated migraine South Med J 97 819 822
45. A Carlsson M Lindqvist M Magnusson 1957 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists Nature 180 1200
46. A Carlsson M Lindqvist T Magnusson B Walbeck 1958 On the presence of 3-hydroxytyramine in brain Science 127 471
47. JD Carroll BP Hilton 1974 The effects of reserpine injection on methysergide treated control and migrainous subjects Headache 14 149 156
48. 1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons Mol Pharmacol 59 1533 1541
49. EM Cassidy E Tomkins T Dinan O Hardiman V O'Keane 2003 Central 5-HT receptor hypersensitivity in migraine without aura Cephalalgia 23 29 34
50. 2B, receptors mediate hypotension in vagosympathectomized rats Eur J Pharmacol 502 239 242
51. R Cerbo P Barbanti MG Buzzi G Fabbrini L Brusa C Roberti E Zanette GL Lenzi 1997 Dopamine hypersensitivity in migraine: role of the apomorphine test Clin Neuropharmacol 20 36 41
52. W Chai S Mehrotra AHJ Danser RG Schoemaker 2006 The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts Eur J Pharmacol 531 246 253
53. JA Charles S Jotkowitz LH Byrd 2006 Prevention of migraine with olmesartan in patients with hypertension/prehypertension Headache 46 503 507
54. JD Classey YE Knight PJ Goadsby 2001 The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat Brain Res 907 117 124
55. JR Clements KR Magnusson J Hautman AJ Beitz 1991 Rat tooth pulp projections to spinal trigeminal subnucleus caudalis are glutamate-like immunoreactive J Comp Neurol 309 281 288
56. Z Cohen G Bonvento P Lacombe E Hamel 1996 Serotonin in the regulation of brain microcirculation Prog Neurobiol 50 335 362
57. NJ Colson RA Lea S Quinlan J MacMillan LR Griffiths 2004 The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups Neurogenetics 5 129 133
58. NJ Colson RA Lea S Quinlan J MacMillan LR Griffiths 2005 Investigation of hormone receptor genes in migraine Neurogenetics 6 17 23
59. SP Cook EW McCleskey 1997 Desensitization, recovery and Ca(2+)-dependent modulation of ATP-gated P2X receptors in nociceptors Neuropharmacology 36 1303 1308
60. SP Cook L Vulchanova KM Hargreaves R Elde EW McCleskey 1997 Distinct ATP receptors on pain-sensing and stretch-sensing neurons Nature 387 505 508
61. 1-adrenergic receptor Proc Natl Acad Sci USA 85 7159 7163
62. Cruickshank JM, Prichard BN (1994) Beta-adrenoceptors. In: Cruickshank JM, Prichard BNC (eds) B-blockers in clinical practice. Churchill Livingstone, Edinburgh, pp 9-86
63. DA Curran H Hinterberger JW Lance 1965 Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects Brain 88 997 1010
64. FM Cutrer 2001 Antiepileptic drugs: how they work in headache Headache 41 Suppl. 1 S3 10
65. FM Cutrer V Limmroth MA Moskowitz 1997 Possible mechanisms of valproate in migraine prophylaxis Cephalalgia 17 93 100
66. Cutrer FM, Limmroth V, Waeber C, Yu X, Moskowitz MA (1997b) New targets for antimigraine drug development. In: Goadsby PJ, Silberstein S (eds) Headache. Butterworth-Heinemann, Philadelphia, pp 59-72
67. M Cyr O Ghribi C Thibault M Morissette M Landry T Di Paolo 2001 Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors Brain Res Rev 37 153 161
68. CG Dahlöf RJ Hargreaves 1998 Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies Cephalalgia 18 593 604
69. G D'Andrea F Granella F Perini A Farruggio M Leone G Bussone 2006 Platelet levels of dopamine are increased in migraine and cluster headache Headache 46 585 591
70. M De Gasparo KJ Catt T Inagami JW Wright T Unger 2000 International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol Rev 52 415 472
71. P De Vries CM Villalón PR Saxena 1999 Pharmacology of triptans Emerging Drugs 4 107 125
72. P De Vries CM Villalón PR Saxena 1999 Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy Eur J Pharmacol 375 61 74
73. E Del Bene M Poggioni S Michelacci 1983 Lisuride as a migraine prophylactic in children: an open clinical trial Int J Clin Pharmacol Res 3 137 141
74. G Di Trapani D Mei C Marra S Mazza A Capuano 2000 Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study Clin Ter 151 145 148
75. HC Diener P Tfelt-Hansen C Dahlof MJ Lainez G Sandrini SJ Wang W Neto U Vijapurkar A Doyle D Jacobs 2004 Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control J Neurol 251 943 950
76. DE Dluzen VD Ramírez 1989 Progesterone enhances l-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats Brain Res 494 122 128
77. 2-adrenoceptors Eur J Pharmacol 361 1 15
78. DW Dodick VT Martin T Smith S Silberstein 2004 Cardiovascular tolerability and safety of triptans: a review of clinical data Headache 44 Suppl 1 S20 S30
79. H Doods G Hallermayer D Wu M Entzeroth K Rudolf W Engel W Eberlein 2000 Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist Br J Pharmacol 129 420 423
80. JP Dreier J Kleeberg G Petzold J Priller O Windmuller HD Orzechowski U Lindauer U Heinemann KM Einhaupl U Dirnagl 2002 Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura Brain 125 102 112
81. PD Drummond JW Lance 1983 Extracranial vascular changes and the source of pain in migraine headache Ann Neurol 13 32 37
82. PD Drummond JW Lance 1984 Facial temperature in migraine, tension-vascular and tension headache Cephalalgia 4 149 158
83. 2 in vitro bioassays Can J Physiol Pharmacol 75 671 676
84. PL Durham 2004 CGRP-receptor antagonists-a fresh approach to migraine therapy N Engl J Med 350 1073 1075
85. L Edvinsson 2004 Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache Cephalalgia 24 611 622
86. L Edvinsson PJ Goadsby 1994 Neuropeptides in migraine and cluster headache Cephalalgia 14 320 327
87. E Enmark JA Gustafsson 1999 Oestrogen receptors-an overview J Intern Med 246 133 138
88. 2A receptor gene with aura in migraine J Neurol Sci 188 99 101
89. V Erspamer 1954 Pharmacology of indolealkylamines Pharmacol Rev 6 425 487
90. V Erspamer B Asero 1952 Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine Nature 169 800 801
91. 2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide J Neurosci 26 6163 6171
92. F Facchinetti E Martignoni G Nappi L Fioroni G Sances AR Genazzani 1989 Premenstrual failure of α-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine Psychosom Med 51 550 558
93. F Facchinetti G Sances P Borella AR Genazzani G Nappi 1991 Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium Headache 31 298 301
94. M Farkkila J Palo O Saijonmaa F Fyhrquist 1992 Raised plasma endothelin during acute migraine attack Cephalalgia 12 383 384
95. JJ Fernández-Ruíz R de Miguel ML Hernández JA Ramos 1990 Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain Pharmacol Biochem Behav 36 603 606
96. 3 receptor antagonists and migraine therapy J Neurol 238 Suppl 1 S53 56
97. MD Ferrari PR Saxena 1993 Clinical and experimental effects of sumatriptan in humans Trends Pharmacol Sci 14 129 133
98. 2B receptor antagonist with improved affinity, selectivity, and oral activity J Med Chem 38 2524 2530
99. 1- Adrenoceptor classification: sharpening Occam's razor Trends Pharmacol Sci 15 167 170
100. B Forssman CJ Lindblad V Zbornikova 1983 Atenolol for migraine prophylaxis Headache 23 188 190
101. JR Fozard HO Kalkman 1994 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives Naunyn-Schmiedeberg's Arch Pharmacol 350 225 229
102. o proteins and inhibits adenylate cyclase in HEK 293 cells Eur J Pharmacol 361 299 309
103. BB Fredholm AP Ijzerman KA Jacobson KN Klotz J Linden 2001 International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 527 552
104. FG Freitag S Diamond 1984 Nadolol and placebo comparison study in the prophylactic treatment of migraine J Am Osteopath Assoc 84 343 347
105. E Fusayasu H Kowa T Takeshima K Nakaso K Nakashima 2007 Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods Pain 128 209 214
106. J Galitzky D Langin P Verwaerde JL Montastruc M Lafontan M Berlan 1997 Lipolytic effects of conventional β3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4-adrenoceptor Br J Pharmacol 122 1244 1250
107. MG Garry LP Walton MA Davis 2000 Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP Brain Res 861 208 219
108. P Geppetti E Del Bianco P Santicioli IT Lippe CA Maggi F Sicuteri 1990 Release of sensory neuropeptides from dural venous sinuses of guinea pig Brain Res 510 58 62
109. 1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis J Mol Cell Cardiol 39 964 971
110. 1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects Cephalalgia 23 287 292
111. PJ Goadsby 2005 New targets in the acute treatment of headache Curr Opin Neurol 18 283 288
112. PJ Goadsby JW Lance 1990 Physiopathology of migraine Rev Prat 40 389 393
113. PJ Goadsby JD Classey 2000 Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow Brain Res 875 119 124
114. 1F receptor inhibitory effects on trigeminal neurons with craniovascular input Neuroscience 122 491 498
115. PJ Goadsby L Edvinsson R Ekman 1988 Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system Ann Neurol 23 193 196
116. PJ Goadsby M Adner L Edvinsson 1996 Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression J Cereb Blood Flow Metab 16 698 704
117. PJ Goadsby RB Lipton MD Ferrari 2002 Migraine-current understanding and treatment N Engl J Med 346 257 270
118. 1 receptor agonists inhibit trigeminovascular nociceptive transmission Brain 125 1392 1401
119. DJ Goldstein O Wang JR Saper R Stoltz SD Silberstein NT Mathew 1997 Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study Cephalalgia 17 785 790
120. DJ Goldstein WW Offen EG Klein LA Phebus P Hipskind KW Johnson RE Ryan Jr 2001 Lanepitant, an NK-1 antagonist, in migraine prevention Cephalalgia 21 102 106
121. 1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial Lancet 358 1230 1234
122. 1D agonist, in patients with acute migraine Cephalalgia 21 727 732
123. S Gupta S Mehrotra CJJ Avezaat CM Villalón PR Saxena A MaassenVanDenBrink 2006 Characterisation of CGRP receptors in the human isolated middle meningeal artery Life Sci 79 265 271
124. S Gupta S Mehrotra CM Villalón IM Garrelds R de Vries JP van Kats HS Sharma PR Saxena A MaassenVanDenBrink 2006 Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity Eur J Pharmacol 530 107 116
125. S Gupta S Mehrotra CM Villalón M Perusquía PR Saxena A MaassenVanDenBrink 2007 Potential role of female sex hormones in the pathophysiology of migraine Pharmacol Ther 113 321 340
126. SG Hamilton SB McMahon 2000 ATP as a peripheral mediator of pain J Auton Nerv Syst 81 187 194
127. MG Hanna 2006 Genetic neurological channelopathies Nat Clin Pract Neurol 2 252 263
128. WL Hasler 1999 Serotonin receptor physiology: relation to emesis Dig Dis Sci 44 108S 113S
129. M Hasselblatt J Kohler E Volles H Ehrenreich 1999 Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine Neuroreport 10 423 425
130. L Hein BK Kobilka 1995 Adrenergic receptor signal transduction and regulation Neuropharmacology 34 357 366
131. R Hering-Hanit 1999 Baclofen for prevention of migraine Cephalalgia 19 589 591
132. ML Hernández JJ Fernández-Ruíz R de Miguel JA Ramos 1991 Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats J Neural Transm Gen Sect 83 77 84
133. WM Herrmann M Kristof M Sastre 1978 Preventive treatment of migraine headache with a new isoergolenyl derivative J Int Med Res 6 476 482
134. H Heyck 1969 Pathogenesis of migraine Research clinical studies Headache 2 1 28
135. JP Hieble 2000 Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics Pharm Acta Helv 74 163 171
136. 1-adrenoceptors: consensus update Pharmacol Rev 47 267 270
137. SJ Hill CR Ganellin H Timmerman JC Schwartz NP Shankley JM Young W Schunack R Levi HL Haas 1997 International union of pharmacology. XIII. Classification of histamine receptors Pharmacol Rev 49 253 278
138. TW Ho LK Mannix X Fan C Assaid C Furtek CJ Jones CR Lines AM Rapoport 2008 Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine Neurology 70 1304 1312
139. Hoffman BB (2001) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, 10th edn. McGraw-Hill, New York
140. 2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis Clin Neuropharmacol 29 80 86
141. 2A receptor gene haplotype is associated with migraine with aura Cephalalgia 27 177 181
142. 1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat Cephalalgia 22 260 264
143. J Honkaniemi S Liimatainen S Rainesalo S Sulavuori 2006 Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study Headache 46 781 787
144. 1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat Brain Res 998 91 99
145. -M receptors Neuropsychopharmacology 3 371 383
146. D Hoyer DE Clarke JR Fozard PR Hartig GR Martin EJ Mylecharane PR Saxena PPA Humphrey 1994 International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46 157 203
147. 1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro Br J Clin Pharmacol 22 535 540
148. PT Hurley RA McMahon P Fanning KM O'Boyle M Rogers F Martin 1998 Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells Br J Pharmacol 124 1238 1244
149. M Iovino U Feifel CL Yong JM Wolters G Wallenstein 2004 Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers Cephalalgia 24 645 656
150. 2B receptor activation in human coronary artery endothelial cells Kobe J Med Sci 44 51 63
151. 2 receptor subtypes in human coronary arteries Cardiovasc Res 41 267 274
152. IUPHAR (2006) 3rd Major update to IUPHAR receptor database. http://www.iuphar-db.org/GPCR/ReceptorFamiliesForward.
153. DL Jackson KM Hargreaves 1999 Activation of excitatory amino acid receptors in bovine dental pulp evokes the release of iCGRP J Dent Res 78 54 60
154. I Jansen-Olesen L Jorgensen U Engel L Edvinsson 2003 In-depth characterization of CGRP receptors in human intracranial arteries Eur J Pharmacol 481 207 216
155. JC Jen J Wan TP Palos BD Howard RW Baloh 2005 Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures Neurology 65 529 534
156. V Johannsson LR Nilsson T Widelius T Javerfalk P Hellman JA Akesson B Olerud CL Gustafsson A Raak G Sandahl 1987 Atenolol in migraine prophylaxis a double-blind cross-over multicentre study Headache 27 372 374
157. 2B receptor activation Cephalalgia 23 117 123
158. 2C receptor blockade Life Sci 54 641 644
159. M Kallela M Farkkila O Saijonmaa F Fyhrquist 1998 Endothelin in migraine patients Cephalalgia 18 329 332
160. K Kapoor U Arulmani JPC Heiligers IM Garrelds EW Willems H Doods CM Villalón PR Saxena 2003 Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs Br J Pharmacol 140 329 338
161. P Kastner A Krust B Turcotte U Stropp L Tora H Gronemeyer P Chambon 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO J 9 1603 1614
162. H Kaube J Herzog T Kaufer M Dichgans HC Diener 2000 Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine Neurology 55 139 141
163. AJ Kaumann 1997 Four β-adrenoceptor subtypes in the mammalian heart Trends Pharmacol Sci 18 70 76
164. MJ Kelly ER Levin 2001 Rapid actions of plasma membrane estrogen receptors Trends Endocrinol Metab 12 152 156
165. RW Kimball AP Friedman E Vallejo 1960 Effect of serotonin in migraine patients Neurology 10 107 111
166. 2-adrenergic receptor Science 238 650 656
167. H Kowa T Shimomura K Takahashi 1992 Platelet gamma-aminobutyric acid levels in migraine and tension-type headache Headache 32 229 232
168. 7 serotonin receptor splice variants: constitutive activity and inverse agonist effects Br J Pharmacol 135 1563 1571
169. PP Lakhlani F Amenta P Napoleone L Felici DC Eikenburg 1994 Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney Br J Pharmacol 111 1296 1308
170. GA Lambert C Donaldson KL Hoskin PM Boers AS Zagami 2004 Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat Naunyn-Schmiedeberg's Arch Pharmacol 369 591 601
171. C Lampl Z Katsarava HC Diener V Limmroth 2005 Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura J Neurol Neurosurg Psychiatry 76 1730 1732
172. AM Lands A Arnold JP McAuliff FP Luduena TG Brown Jr 1967 Differentiation of receptor systems activated by sympathomimetic amines Nature 214 597 598
173. 2-adrenergic receptor. Identification of a unique receptor subtype J Biol Chem 266 10470 10478
174. 1-receptor. Support for the NO hypothesis of migraine Neuroreport 6 1475 1479
175. LH Lassen LL Thomsen C Kruuse HK Iversen J Olesen 1996 Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine Eur J Clin Pharmacol 49 335 339
176. LH Lassen M Ashina I Christiansen V Ulrich R Grover J Donaldson J Olesen 1998 Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks Cephalalgia 18 27 32
177. YT Lau 2002 Receptor-dependent and genomic-independent actions of estrogen in vascular protection Chang Gung Med J 25 636 644
178. A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation Br J Pharmacol 116 1661 1667
179. 1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study Headache 45 1004 1011
180. KP Lesch B Lerer 1991 The 5-HT receptor-G-protein-effector system complex in depression. I. Effect of glucocorticoids J Neural Transm Gen Sect 84 3 18
181. LE Limbird 1988 Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms Faseb J 2 2686 2695
182. V Limmroth MC Michel 2001 The prevention of migraine: a critical review with special emphasis on β-adrenoceptor blockers Br J Clin Pharmacol 52 237 243
183. RB Lipton WF Stewart S Diamond ML Diamond M Reed 2001 Prevalence and burden of migraine in the United States: data from the American Migraine Study II Headache 41 646 657
184. R Lodi GJ Kemp P Montagna G Pierangeli P Cortelli S Iotti GK Radda B Barbiroli 1997 Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache J Neurol Sci 146 73 80
185. 1A-adrenergic receptor. The gene for which is located on human chromosome 5 J Biol Chem 266 6365 6369
186. AE Luebke GP Dahl BA Roos IM Dickerson 1996 Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay Proc Natl Acad Sci USA 93 3455 3460
187. 1B/1D/1F receptors and glutamate in trigeminal ganglia in rats Neuroreport 12 1589 1591
188. A MaassenVanDenBrink M Reekers WA Bax MD Ferrari PR Saxena 1998 Coronary side-effect potential of current and prospective antimigraine drugs Circulation 98 25 30
189. A MaassenVanDenBrink RWM van den Broek R de Vries AJC Bogers CJJ Avezaat PR Saxena 2000 Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels Neurology 55 1524 1530
190. EA MacGregor 2006 Migraine and the menopause J Br Menopause Soc 12 104 108
191. EA MacGregor A Hackshaw 2002 Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements J Fam Plann Reprod Health Care 28 27 31
192. EA MacGregor A Frith J Ellis L Aspinall A Hackshaw 2006 Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study Neurology 67 2159 2163
193. EA MacGregor A Frith J Ellis L Aspinall A Hackshaw 2006 Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen Neurology 67 2154 2158
194. AL Magos KJ Zilkha JW Studd 1983 Treatment of menstrual migraine by oestradiol implants J Neurol Neurosurg Psychiatry 46 1044 1046
195. F Marceau D Regoli 2004 Bradykinin receptor ligands: therapeutic perspectives Nat Rev Drug Discov 3 845 852
196. VT Martin M Behbehani 2006 Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I Headache 46 3 23
197. F Martínez J Castillo JR Rodríguez R Leira M Noya 1993 Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks Cephalalgia 13 89 93
198. NT Mathew J Kailasam L Meadors O Chernyschev P Gentry 2000 Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report Headache 40 720 723
199. T Matsubara MA Moskowitz Z Huang 1992 UK-14,304, R(-)-alpha-methyl- histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms Eur J Pharmacol 224 145 150
200. 2 receptor gene is not associated with either migraine or Parkinson's disease Psychiatr Genet 11 49 52
201. A May HJ Gijsman A Wallnofer R Jones HC Diener MD Ferrari 1996 Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks Pain 67 375 378
202. A May SL Shepheard M Knorr R Effert A Wessing RJ Hargreaves PJ Goadsby HC Diener 1998 Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine Brain 121 Pt 7 1231 1237
203. A May C Buchel R Turner PJ Goadsby 2001 Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation J Cereb Blood Flow Metab 21 1171 1176
204. 1D receptor agonist PNU-142633 Cephalalgia 22 799 806
205. LM McLatchie NJ Fraser MJ Main A Wise J Brown N Thompson R Solari MG Lee SM Foord 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 333 339
206. 4 receptor in the central nervous system by TaqMan real time RT-PCR Brain Res Mol Brain Res 90 125 134
207. S Mehrotra S Gupta IM Garrelds CM Villalón PR Saxena AJJC Bogers A MaassenVanDenBrink 2006 Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery Naunyn-Schmiedeberg's Arch Pharmacol 374 163 175
208. S Mehrotra S Gupta CM Villalón F Boomsma PR Saxena A MaassenVanDenBrink 2007 Rat carotid artery responses to α-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement Headache 47 236 246
209. 2B-adrenoceptor subtypes Br J Pharmacol 98 890 897
210. 1-adrenergic receptor regulation: basic science and clinical implications Pharmacol Ther 88 281 309
211. RO Millán-Guerrero AG Pineda-Lucatero T Hernández-Benjamin CE Tene MF Pacheco 2003 N-alpha-methylhistamine safety and efficacy in migraine prophylaxis: phase I and phase II studies Headache 43 389 394
212. RO Millán-Guerrero R Isais-Millán TH Benjamin CE Tene 2006 N-alpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III study Can J Neurol Sci 33 195 199
213. DS Millson SJ Tepper AM Rapoport 2000 Migraine pharmacotherapy with oral triptans: a rational approach to clinical management Expert Opin Pharmacother 1 391 404
214. DD Mitsikostas M Sanchez del Rio C Waeber MA Moskowitz FM Cutrer 1998 The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis Pain 76 239 248
215. DD Mitsikostas M Sanchez del Rio C Waeber Z Huang FM Cutrer MA Moskowitz 1999 Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis Br J Pharmacol 127 623 630
216. M Mochi S Cevoli P Cortelli G Pierangeli S Soriani C Scapoli P Montagna 2003 A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes Neurol Sci 23 301 305
217. I Mody JD Lambert U Heinemann 1987 Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices J Neurophysiol 57 869 888
218. ME Moreau N Garbacki G Molinaro NJ Brown F Marceau A Adam 2005 The kallikrein-kinin system: current and future pharmacological targets J Pharmacol Sci 99 6 38
219. MA Moskowitz FM Cutrer 1993 Sumatriptan: a receptor-targeted treatment for migraine Annu Rev Med 44 145 154
220. MA Moskowitz MG Buzzi DE Sakas MD Linnik 1989 Pain mechanisms underlying vascular headaches. Progress Report 1989 Rev Neurol 145 181 193
221. 2- adrenergic receptors in the OK cell, an opossum kidney cell line J Pharmacol Exp Ther 244 571 578
222. 2-adrenoceptors in the trigeminal region produces sex-specific modulation of nociception in the rat Neuroscience 142 1255 1262
223. J Olesen RB Lipton 1994 Migraine classification and diagnosis. International Headache Society criteria Neurology 44 S6 10
224. J Olesen HC Diener IW Husstedt PJ Goadsby D Hall U Meier S Pollentier LM Lesko 2004 Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine N Engl J Med 350 1104 1110
225. KR Oliver A Wainwright L Edvinsson JD Pickard RG Hill 2002 Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature J Cereb Blood Flow Metab 22 620 629
226. 2+ channel gene CACNL1A4 Cell 87 543 552
227. JM Orshal RA Khalil 2004 Gender, sex hormones, and vascular tone Am J Physiol Regul Integr Comp Physiol 286 R233 249
228. M Oshita S Kigoshi I Muramatsu 1991 Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex Br J Pharmacol 104 961 965
229. IH Page 1954 Serotonin (5 Hydroxytryptamine) Physiol Rev 34 563 588
230. JE Palmer EP Chronicle P Rolan WM Mulleners 2000 Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients Cephalalgia 20 525 532
231. S Paterna P Di Pasquale D A Angelo G Seidita A Tuttolomondo A Cardinale T Maniscalchi G Follone A Giubilato M Tarantello G Licata 2000 Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura Eur Neurol 43 133 136
232. M Peeters MJ Gunthorpe PJ Strijbos P Goldsmith N Upton MF James 2007 Effects of pan- and subtype-selective NMDA receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine J Pharmacol Exp Ther 312 564 572
233. 1D-adrenergic receptor cDNA Mol Pharmacol 40 876 883
234. SJ Peroutka 1988 Antimigraine drug interactions with serotonin receptor subtypes in human brain Ann Neurol 23 500 504
235. SJ Peroutka 1997 Dopamine and migraine Neurology 49 650 656
236. SJ Peroutka 2004 Migraine: a chronic sympathetic nervous system disorder Headache 44 53 64
237. SJ Peroutka 2005 Neurogenic inflammation and migraine: implications for the therapeutics Mol Interv 5 304 311
238. 2 receptor (DRD2) NcoI alleles Neurology 49 201 206
239. 2 receptor (DRD2) NcoI alleles Mol Med 4 14 21
240. KA Petersen E Nilsson J Olesen L Edvinsson 2005 Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo Cephalalgia 25 424 432
241. KA Petersen LH Lassen S Birk L Lesko J Olesen 2005 BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation Clin Pharmacol Ther 77 202 213
242. 1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine Life Sci 61 2117 2126
243. 1B-adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides J Pharmacol Exp Ther 283 854 868
244. ai/o-proteins Mol Pharmacol 61 85 96
245. 7 receptor antagonist of potential clinical interest CNS Drug Rev 8 90 100
246. KJ Powell W Ma M Sutak H Doods R Quirion K Jhamandas 2000 Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists Br J Pharmacol 131 875 884
247. DR Poyner PM Sexton I Marshall DM Smith R Quirion W Born R Muff JA Fischer SM Foord 2002 International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors Pharmacol Rev 54 233 246
248. 1D receptors Naunyn-Schmiedeberg's Arch Pharmacol 356 312 320
249. M Quartu MP Serra R Ambu ML Lai M Del Fiacco 2002 AMPA-type glutamate receptor subunits 2/3 in the human trigeminal sensory ganglion and subnucleus caudalis from prenatal ages to adulthood Mech Ageing Dev 123 463 471
250. 2 receptor subtypes Ann N Y Acad Sci 657 88 105
251. R Rabkin DP Stables NW Levin MM Suzman 1966 The prophylactic value of propranolol in angina pectoris Am J Cardiol 18 370 383
252. NM Ramadan H Halvorson A Vande-Linde SR Levine JA Helpern KMA Welch 1989 Low brain magnesium in migraine Headache 29 590 593
253. NM Ramadan LL Schultz SJ Gilkey 1997 Migraine prophylactic drugs: proof of efficacy, utilization and cost Cephalalgia 17 73 80
254. 1F receptor agonists in acute migraine treatment: a hypothesis Cephalalgia 23 776 785
255. MM Rapport AA Green IH Page 1948 Serum vasoconstrictor (serotonin). IV. Isolation and characterization J Biol Chem 176 1243 1251
256. BK Rasmussen R Jensen M Schroll J Olesen 1991 Epidemiology of headache in a general population-a prevalence study J Clin Epidemiol 44 1147 1157
257. 2- adrenergic receptor subtype Proc Natl Acad Sci USA 85 6301 6305
258. P Roffey M Mikhail D Thangathurai 2001 NMDA receptor blockade prevents nitroglycerin-induced headaches Headache 41 733
259. KI Roon J Olesen HC Diener P Ellis J Hettiarachchi PH Poole I Christianssen D Kleinermans JG Kok MD Ferrari 2000 No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials Ann Neurol 47 238 241
260. 3 receptor agonist prodrug J Pharmacol Exp Ther 281 1085 1094
261. Y Sahara N Noro Y Iida K Soma Y Nakamura 1997 Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons J Neurosci 17 6611 6620
262. CA Salvatore JC Hershey HA Corcoran JF Fay VK Johnston EL Moore SD Mosser CS Burgey DV Paone AW Shaw SL Graham JP Vacca TM Williams KS Koblan SA Kane 2008 Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3- difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3- yl]-4-(2-oxo-2,3- dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine J Pharmacol Exp Ther 324 416 421
263. CN Sang NM Ramadan RG Wallihan AS Chappell FG Freitag TR Smith SD Silberstein KW Johnson LA Phebus D Bleakman PL Ornstein B Arnold SJ Tepper F Vandenhende 2004 LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine Cephalalgia 24 596 602
264. P Sarchielli G Coata C Firenze P Morucci G Abbritti V Gallai 1992 Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients Cephalalgia 12 21 27
265. 2+, and serotonin content in platelets from patients suffering from chronic daily headache Cephalalgia 19 810 816
266. 4-adrenoceptor' in rat atrium Br J Pharmacol 123 371 380
267. PR Saxena CM Villalón 1990 Cardiovascular effects of serotonin agonists and antagonists J Cardiovasc Pharmacol 15 Suppl 7 S17 S34
268. 1B/1D receptor agonists in the acute treatment of migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches. Lippincott Williams & Wilkins, Philadelphia, pp 411-38
269. 1A receptors, in an animal model of migraine: comparison with propranolol and pindolol Eur J Pharmacol 220 79 86
270. 1-like receptors: a time to bid goodbye Trends Pharmacol Sci 19 311 316
271. 2C receptors and their possible relevance to antimigraine efficacy Br J Pharmacol 140 277 284
272. 2B receptors: an early step in the generation of migraine headache Eur J Neurosci 8 959 967
273. H Schrader LJ Stovner G Helde T Sand G Bovim 2001 Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study Brit Med J 322 19 22
274. V Shaygannejad M Janghorbani A Ghorbani F Ashtary N Zakizade V Nasr 2006 Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study Headache 46 642 648
275. 1F receptor agonist LY334370 Cephalalgia 19 851 858
276. JC Shih W Yang K Chen T Gallaher 1991 Molecular biology of serotonin 5-HT receptors Pharmacol Biochem Behav 40 1053 1058
277. SD Silberstein 1998 Methysergide Cephalalgia 18 421 435
278. SD Silberstein 2000 Sex hormones and headache Rev Neurol 156 Suppl 4 4S30 4S41
279. SD Silberstein W Neto J Schmitt D Jacobs 2004 Topiramate in migraine prevention: results of a large controlled trial Arch Neurol 61 490 495
280. AP Silva C Cavadas E Grouzmann 2002 Neuropeptide Y and its receptors as potential therapeutic drug targets Clin Chim Acta 326 3 25
281. 2D-adrenergic receptors in bovine pineal gland Mol Pharmacol 40 235 241
282. GW Smith JB Farmer F Ince K Matu PD Mitchell I Naya B Springthorpe 1990 FPL 63012AR: a potent D1-receptor agonist Br J Pharmacol 100 295 300
283. LJ Smith JA Henderson CW Abell CL Bethea 2004 Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques Neuropsychopharmacology 29 2035 2045
284. BW Somerville 1975 Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration Neurology 25 245 250
285. BW Somerville WM Herrmann 1978 Migraine prophylaxis with lisuride hydrogen maleate-a double blind study of Lisuride versus placebo Headache 18 75 79
286. M Spedding TI Bonner SP Watson 2002 International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric G protein-coupled receptors Pharmacol Rev 54 231 232
287. 2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks Headache 42 566 574
288. S Stellar SP Ahrens AR Meibohm SA Reines 1984 Migraine prevention with timolol. A double-blind crossover study JAMA 252 2576 2580
289. WF Stewart RB Lipton DD Celentano ML Reed 1992 Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors JAMA 267 64 69
290. GL Stiles MG Caron RJ Lefkowitz 1984 β-adrenergic receptors: biochemical mechanisms of physiological regulation Physiol Rev 64 661 743
291. RJ Storer PJ Goadsby 1999 Trigeminovascular nociceptive transmission involves N-methyl-d-aspartate and non-N-methyl-d-aspartate glutamate receptors Neuroscience 90 1371 1376
292. RJ Storer S Akerman PJ Goadsby 2004 Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat Br J Pharmacol 142 1171 1181
293. A receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil Brain Res 1013 188 193
294. A Sudilovsky AH Elkind RE Ryan Sr JR Saper MA Stern JH Meyer 1987 Comparative efficacy of nadolol and propranolol in the management of migraine Headache 27 421 426
295. T Takenaka H Forster M Epstein 1993 Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435 J Pharmacol Exp Ther 264 1154 1159
296. SJ Tallaksen-Greene AB Young JB Penney AJ Beitz 1992 Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat Neurosci Lett 141 79 83
297. 1-adrenoceptor function in health and disease from transgenic animal studies Trends Endocrinol Metab 14 107 113
298. SJ Tepper 2001 Safety and rational use of the triptans Med Clin North Am 85 959 970
299. 7 receptor mRNA expression in human trigeminal ganglia Neurosci Lett 302 9 12
300. GM Terwindt RA Ophoff R van Eijk MN Vergouwe J Haan RR Frants LA Sandkuijl MD Ferrari 2001 Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura Neurology 56 1028 1032
301. Tfelt-Hansen P, Rolan P (2006) β-Adrenoceptor blocking drugs in migraine prophylaxis. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches. Lippincott Williams & Wilkins, Philadelphia, pp 519-528
302. P Tfelt-Hansen B Standnes P Kangasneimi H Hakkarainen J Olesen 1984 Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial Acta Neurol Scand 69 1 8
303. 5A receptors as a therapeutic target Pharmacol Ther 111 707 714
304. 7 receptors Curr Drug Targets CNS Neurol Disord 3 81 90
305. E Tronvik LJ Stovner G Helde T Sand G Bovim 2003 Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial JAMA 289 65 69
306. C Tzourio M El Amrani O Poirier V Nicaud MG Bousser A Alperovitch 2001 Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism Neurology 56 1273 1277
307. R Uddman L Edvinsson R Ekman T Kingman J McCulloch 1985 Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P Neurosci Lett 62 131 136
308. LL van de Ven CL Franke PJ Koehler 1997 Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study Cephalalgia 17 596 599
309. 1D receptor antagonists and in situ hybridization Cephalalgia 22 83 93
310. AM van den Maagdenberg J Haan GM Terwindt MD Ferrari 2007 Migraine: gene mutations and functional consequences Curr Opin Neurol 20 299 305
311. 1 adrenergic receptor subtypes in the regulation of arterial pressure Life Sci 57 2291 2308
312. CM Villalón D Centurión 2007 Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications Naunyn-Schmiedeberg's Arch Pharmacol 376 45 63
313. 1D receptor subtypes Eur J Pharmacol 190 167 176
314. CM Villalón D Centurión LF Valdivia P De Vries PR Saxena 2002 An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy Proc West Pharmacol Soc 45 199 210
315. CM Villalón E Ramírez-San Juan A Sanchez-Lopez G Bravo EW Willems PR Saxena D Centurión 2003 Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation Pharmacol Toxicol 92 165 172
316. A Wackenfors M Jarvius R Ingemansson L Edvinsson M Malmsjo 2005 Triptans induce vasoconstriction of human arteries and veins from the thoracic wall J Cardiovasc Pharmacol 45 476 484
317. 2B-adrenergic receptor Mol Pharmacol 38 681 688
318. B Weiss A Alt AM Ogden M Gates DK Dieckman A Clemens-Smith KH Ho K Jarvie G Rizkalla RA Wright DO Calligaro D Schoepp EL Mattiuz RE Stratford B Johnson C Salhoff M Katofiasc LA Phebus K Schenck M Cohen SA Filla PL Ornstein KW Johnson D Bleakman 2006 Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo J Pharmacol Exp Ther 318 772 781
319. KMA Welch E Chabi K Bartosh VS Achar JS Meyer 1975 Cerebrospinal fluid gamma aminobutyric acid levels in migraine Br Med J 3 516 517
320. 2 receptors: cardiovascular hope or hype Br J Pharmacol 140 809 824
321. 2-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation Br J Pharmacol 132 1292 1298
322. 1-Adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development Cephalalgia 21 110 119
323. EW Willems LF Valdivia CM Villalón PR Saxena 2002 α-Adrenoceptors and acute migraine therapy Drug News Perspect 15 140 146
324. EW Willems LF Valdivia CM Villalón PR Saxena 2003 Possible role of alpha-adrenoceptor subtypes in acute migraine therapy Cephalalgia 23 245 257
325. R Würz R Benmalek KH Grotemeyer M Foh 1991 Bisoprolol and metoprolol in the prophylactic treatment of migraine with and without aura-a randomized double-blind cross-over multicenter study Cephalalgia 11 152 153
326. M Yanagisawa H Kurihara S Kimura Y Tomobe M Kobayashi Y Mitsui Y Yazaki K Goto T Masaki 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411 415
327. CY Yu NM Boyd SJ Cringle EN Su VA Alder DY Yu 2002 Agonist-induced vasoactive responses in isolated perfused porcine dental pulpal arterioles Arch Oral Biol 47 99 107
328. Y Zhang BR Bhavnani 2005 Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release BMC Neurosci 6 13
329. Z Zhang CS Winborn B Marquez de Prado AF Russo 2007 Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion J Neurosci 27 2693 2703
330. 2 release in isolated rat dura mater Pain 97 259 265